HHLR ADVISORS, LTD.
SuperinvestorHHLR Advisors (Hillhouse)
- SEC CIK
- 0001762304
- Manager
- Zhang Lei
- Style
- Growth
CTKB holding history
Cytek Biosciences, Inc.
Every 13F filing in which HHLR Advisors (Hillhouse) reported holding CTKB, plus the quarters it sold out. Changes compare share counts with the previous calendar quarter.
CTKB overviewAll 13F holders of CTKBFull portfolio
| Quarter | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Q2 2026 | 6,657,030 | $29.49M | 3.54% | 00.0% | Unchanged |
| Q1 2026 | 6,657,030 | $29.09M | 1.74% | 00.0% | Unchanged |
| Q4 2025 | 6,657,030 | $33.62M | 1.08% | 00.0% | Unchanged |
| Q3 2025 | 6,657,030 | $23.1M | 0.56% | 00.0% | Unchanged |
| Q2 2025 | 6,657,030 | $22.63M | 0.73% | 00.0% | Unchanged |
| Q1 2025 | 6,657,030 | $26.69M | 0.75% | 00.0% | Unchanged |
| Q4 2024 | 6,657,030 | $43.2M | 1.50% | 00.0% | Unchanged |
| Q3 2024 | 6,657,030 | $36.88M | 0.81% | 00.0% | Unchanged |
| Q2 2024 | 6,657,030 | $37.15M | 0.92% | 00.0% | Unchanged |
| Q1 2024 | 6,657,030 | $44.67M | 0.97% | 00.0% | Unchanged |
| Q4 2023 | 6,657,030 | $60.71M | 1.22% | 00.0% | Unchanged |
| Q3 2023 | 6,657,030 | $36.75M | 0.82% | 00.0% | Unchanged |
| Q2 2023 | 6,657,030 | $56.85M | 1.21% | −1,046,484−13.6% | Reduced |
| Q1 2023 | 7,703,514 | $70.8M | 1.26% | −981,016−11.3% | Reduced |
| Q4 2022 | 8,684,530 | $88.67M | 1.87% | −72,500−0.8% | Reduced |
| Q3 2022 | 8,757,030 | $128.9M | 3.39% | 00.0% | Unchanged |
| Q2 2022 | 8,757,030 | $93.96M | 2.01% | 00.0% | Unchanged |
| Q1 2022 | 8,757,030 | $94.4M | 1.97% | 00.0% | Unchanged |
| Q4 2021 | 8,757,030 | $142.92M | 2.21% | 00.0% | Unchanged |
| Q3 2021 | 8,757,030 | $187.49M | 2.45% | +8,757,030 | New |